LobbyingData.com Logo

Amyris, Inc. (AMRS): all U.S. lobbying, including historical lobbying contracts, government bills and agencies, and critical issues lobbied on.


Discover Amyris Biotechnologies’s lobbying activities with our comprehensive dataset, offering insights on spending, bills, and issues from 1999-present. Analyze data by company, lobbyist, issue, and more through our intelligently crafted data design. Dataset updated weekly.


Using our intelligently designed and intuitive dataset, you can quickly understand how Amyris, Inc. (AMRS) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.

Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.

For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.

Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.

Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:

1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.

2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.

3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).

4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.

5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).

6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).

7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).

Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].

Frequently Asked Questions

What is Amyris, Inc. (AMRS) lobbying for?

The lobbying data includes information on Amyris Biotechnologies’ 10 most recent lobbying contracts, detailing the lobbying firms they hired, the general and specific issues they lobbied on, and the government agencies they lobbied. The lobbying firms hired by Amyris Biotechnologies included Llp, Signal Group Consulting, Llc, and Brownstein Hyatt Farber Schreck. The company lobbied on a range of general issues, including Clean Air and Water quality, Taxation/Internal Revenue Code, Defense, Fuel/Gas/Oil, Environment/Superfund, Energy/Nuclear, Trade (domestic/foreign), Science/Technology, Agriculture, and Budget/Appropriations. The specific issues they lobbied on included a variety of federal policies and legislation related to renewable fuels and climate change, such as the American Clean Energy and Security Act of 2009, the Clean Energy Jobs and American Power Act, and the Second Generation Biofuel Producer Tax Credit Act of 2009.

One could infer that Amyris Biotechnologies is lobbying on these issues in order to advance their interests as a biotechnology company focused on developing and commercializing sustainable, renewable products derived from plant sugars. Specifically, the company’s focus on developing second-generation biofuels and other renewable fuels suggests a desire to secure federal support for their research and development efforts and incentivize the commercialization of their products in the United States. Additionally, their interest in climate change and energy policy could reflect a broader effort to position themselves as leaders in the development of low-carbon products and technologies, and to secure funding and support for these efforts from federal agencies like the Department of Energy, Department of Agriculture, and Environmental Protection Agency.

Subscribe To Our Newsletter

gain actionable insights from our alternative data

More to explore